/LIPUM.ST
LIPUM.ST Stock - Lipum AB (publ)
Healthcare|BiotechnologySTO
$14.55+0.34%
+$0.05 (+0.34%) • Dec 23
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.71
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $16.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LIPUM.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.40 – $14.70
TARGET (TP)$16.73
STOP LOSS$13.39
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.28
52W High$21.20
52W Low$8.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $53,000 | N/A | N/A | $14,803 |
| Gross Profit | $-50,000 | $53,000 | $-11,000 | N/A | $-31,731,026 |
| Gross Margin | N/A | 100.0% | N/A | N/A | -214355.4% |
| Operating Income | $-55,221,000 | $-37,254,000 | $-37,925,000 | $-52,106,000 | $-21,057,913 |
| Net Income | $-55,516,000 | $-37,178,000 | $-38,245,000 | $-52,406,000 | $-21,137,413 |
| Net Margin | N/A | -70147.2% | N/A | N/A | -142791.4% |
| EPS | $-3.22 | $-4.45 | $-6.02 | $-12.62 | $-4.18 |
Company Overview
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LIPUM.STBeat Rate
0%
Last 1 quarters
Avg Surprise
-307.0%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.65
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
-307.0%
$-0.65vs$-0.16
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 27, 2025 | $-0.16 | $-0.65 | -307.0% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | — | $-0.83 | — | — |
Q2 2025 | Apr 24, 2025 | — | $-0.90 | — | — |
Q1 2025 | Feb 26, 2025 | — | $-1.21 | — | — |
Q4 2024 | Oct 25, 2024 | — | $-0.08 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-1.09 | — | — |
Q2 2024 | May 7, 2024 | — | $-0.94 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.98 | — | — |
Q4 2023 | Oct 31, 2023 | — | $-0.68 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-1.82 | — | — |
Q2 2023 | Apr 25, 2023 | — | $-0.94 | — | — |
Q1 2023 | Mar 24, 2023 | — | $-1.71 | — | — |
Q4 2022 | Nov 25, 2022 | — | $-1.51 | — | — |
Q3 2022 | Jul 27, 2022 | — | $-1.42 | — | — |
Q2 2022 | May 18, 2022 | — | $-1.15 | — | — |
Q1 2022 | Mar 25, 2022 | — | $-1.11 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-7.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-2.16 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.21 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-1.93 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LIPUM.ST
What is LIPUM.ST's current stock price?
Lipum AB (publ) (LIPUM.ST) is currently trading at $14.55 per share. The stock has moved +0.34% today.
What is the analyst price target for LIPUM.ST?
No analyst price targets are currently available for this stock.
What sector is Lipum AB (publ) in?
Lipum AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is LIPUM.ST's market cap?
Lipum AB (publ) has a market capitalization of $0.31 billion, making it a small-cap company.
Does LIPUM.ST pay dividends?
No, Lipum AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
ANNX.ST
Annexin Pharmaceuticals AB (publ)
$19.00
Mkt Cap: $0.1B
BIOWKS.ST
Bio-Works Technologies AB (publ)
$2.25
Mkt Cap: $0.2B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
INIT.ST
Initiator Pharma A/S
$2.93
Mkt Cap: $0.2B
IRLAB-A.ST
IRLAB Therapeutics AB (publ)
$1.97
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
KDEV.ST
Karolinska Development AB (publ)
$0.43
Mkt Cap: $0.1B
MNTC.ST
Mentice AB (publ)
$13.05
Mkt Cap: $0.4B
Explore stocks similar to LIPUM.ST for comparison